In vivo Anticancer Activities of Benzophenone Semicarbazone against Ehrlich Ascites Carcinoma Cells in Swiss Albino Mice

References

1. ↵
   2. Venkatesh P.

   Synthesis, characterization and antimicrobial activity of various schiff bases complexes of Zn(II) and Cu(II) ions. Asian J Pharm Hea Sci 2011; 1: 8–11.

   OpenUrl
2. 2. Hussein MA,
   3. Omar RH,
   4. Farghaly HS.

   Design, synthesis, structure elucidation and biochemical evaluation of some schiff's base derivatives bearing pyrazolo [3,4-D] pyrimidine-4-ones. Int J Acad Res 2011; 3: part-(II), 454–462.

   OpenUrl
3. ↵
   2. Nair R,
   3. Shah A,
   4. Baluja S, et al.

   Synthesis and antibacterial activity of some schiff base complexes. J Serb Chem Soc 2006; 71: 733–744.

   OpenUrl
4. ↵
   2. Sathe BS,
   3. Jaychandran E,
   4. Jagtap VA, et al.

   Synthesis characterization and anti-inflammatory evaluation of new fluorobenzothiazole schiff's bases. Int J Pharm Res Dev 2011; 3: 164–169.

   OpenUrl
5. ↵
   2. Pandey A,
   3. Dewangan D,
   4. Verma S, et al.

   Synthesis of schiff bases of 2-amino-5-aryl-1, 3, 4-thiadiazole and its analgesic, anti-inflammatory, antibacterial and antitubercular activity. Int J Chem Tech Res 2011; 3: 178–184.

   OpenUrl
6. ↵
   2. Fahmy HH,
   3. El-Eraky W.

   Synthesis and evaluation of analgesic and anti-inflammatory activities of O- substituted salicylamides. Arch Pharm Res 2001; 24: 171–179.

   OpenUrlPubMed
7. ↵
   2. Chinnasamy RP,
   3. Sundararagan R,
   4. Govindaraj S.

   Synthesis, characterization and analgesic activity of novel Schiff base isatin derivatives. J Adv Pharm Technol Res 2010; 1: 342–347.

   OpenUrl
8. ↵
   2. Ali MM,
   3. Jesmin M,
   4. Salam SMA, et al.

   Pesticidal activities of some schiff bases derived from benzoin, salicylaldehde, aminophenol and 2, 4- dinitrophenyl hydrazine. J Sci Res 2009; 1: 641–646.

   OpenUrl
9. ↵
   2. Jesmin M,
   3. Ali MM,
   4. Islam MN, et al.

   Pesticidal Activity of some Schiff Base Complexes Derived from some Divalent Metal Acetates, Glycine and Salicylaldehyde. J Sci Found 2008; 6: 49–56.

   OpenUrl
10. ↵
    2. Ali MM,
    3. Azad MAK,
    4. Jesmin M,
    5. Ahsan et al.

    In vivo anticancer activity of vanillin semicarbazone. Asian Pac J Trop Biomed 2012;438–442.
11. ↵
    2. Loewenthal H,
    3. Jahn G.

    Übertragung-Suersuche Mit Carcinomatöser Mause-Asciteslussigleit Und hr Verhalten Gegen Physikalische Und Chemische Einwirkungen. Z Krebsforsch 1932; 37: 439.

    OpenUrlCrossRef
12. ↵
    2. Ehrlich P.

    Experimentelle studien an mäusetumoren. Berlin, Ztschr f. Krebsforsch 1907; 5: 59–80.

    OpenUrl
13. ↵
    2. Khanam JA,
    3. Islam MF,
    4. Jesmin M, et al.

    Antineoplastic activity of acetone semicarbazone (ASC) against ehrlich ascites carcinoma (EAC) bearing mice. J Natl Sci Found Sri Lanka 2010; 38: 225–231.

    OpenUrl
14. ↵
    2. Qiao X,
    3. Ma ZY,
    4. Xie CZ, et al.

    Study on potential antitumor mechanism of a novel Schiff base copper (II) complex: Synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity. J Inorg Biochem 2011; 105: 728–737.

    OpenUrlPubMed
15. 2. Ali MM,
    3. Jesmin M,
    4. Islam MN, et al.

    Anticancer activities of some transition metal complexes of a schiff base derived from salicylaldehyde and glycine. ACGC Chem Res Comm 2009; 23: 13–22.

    OpenUrl
16. ↵
    2. Khanam JA,
    3. Salahuddin MS,
    4. Habib MR, et al.

    Antineoplastic Activity of Bis-tyrosinediaqua Ni(II) against Ehrlich Ascites Carcinoma. DU J Phar Sci 2008; 7: 33–37.

    OpenUrl
17. ↵
    2. Price VE,
    3. Greenfield RE.

    Anemia in cancer. Adv Cancer Res 1958; 5: 199.

    OpenUrlCrossRefPubMed
18. ↵
    2. Hoagland HC.

    Hematological complication of cancer chemotherapy. Semin Oncol 1982; 9: 95.

    OpenUrlPubMedWeb of Science
19. ↵
    2. Jesmin M,
    3. Ali MM,
    4. Khanam JA.

    Antitumor activities of some schiff bases derived from benzoin, salicylaldehyde, amino phenol and 2, 4-dinitrophenyl hydrozine. Thai J Pharm Sci 2010; 34: 20–31.

    OpenUrl
20. ↵
    2. Ali MM,
    3. Jesmin M,
    4. Sarker MK, et al.

    Antineoplastic activity of N-salicylideneglycinato-di-aquanickel (II) complex against Ehrlich Ascites Carcinoma (EAC) cells in mice. Int J Biol Chem Sci 2008; 2: 292–298.

    OpenUrl
21. ↵
    2. Hudson L.,
    3. Hay F.C.

    2. Hudson L and
    3. Hay FC.

    Isolation of normal peritoneal macrophages. In Practical Immunology, 3rd edn, Hudson L., Hay F.C. (eds) Blackwell Sci. Pub. Oxford, London 1989;26–28.
22. ↵
    2. Jesmin M,
    3. Ali MM,
    4. Biswas MK, et al.

    Antineoplastic Activity of Nickel (II) Cystine Complex against Ehrlich Ascites Carcinoma in Swiss Albino Mice. Med J Isl W Acad Sci (Turkey) 2007; 16: 135–142.

    OpenUrl
23. ↵
    2. Clarkson BD,
    3. Buirchenal JH.

    Preleminary screening of antineoplastic drugs. Prog Clin Cancer 1965; 1: 625–629.

    OpenUrl
24. ↵
    2. Fenninger LD,
    3. Mider GB.

    Energy and nitrogen metabolism in cancer. Adv cancer Res 1954; 2: 229–253.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    2. Burger A.

    Medicinal Chemistry, Vol 2 (3rd ed.), John Wiley and Sons, London, 1981; 602–653.

    OpenUrl
26. ↵
    2. Lee NN,
    3. Cadman EC,
    4. Michael IN, et al.

    Randomized study comparing doxorubicin, cyclophosphomide, vincristine, methotrexate with leucovorin rescue and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. Cancer Treat report 1982; 66: 1279–1284.

    OpenUrlPubMed